On January 24, 2023, Tandem Diabetes Care Inc. (NASDAQ: TNDM) opened at $41.53, lower -0.36% from the last session. During the day, the shares moved up to $41.93 and dropped to $41.25 before settling in for the closing price of $41.74. Price fluctuations for TNDM have ranged from $33.51 to $125.53 over the past 52 weeks.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Healthcare Sector giant saw their annual sales surged by 52.80% over the last five years. Company’s average yearly earnings per share was noted 142.90% at the time writing. With a float of $62.97 million, this company’s outstanding shares have now reached $64.24 million.
The firm has a total of 2000 workers. Let’s measure their productivity. In terms of profitability, gross margin is +51.87, operating margin of +3.22, and the pretax margin is +2.26.
Tandem Diabetes Care Inc. (TNDM) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The most recent insider transaction that took place on Dec 16, was worth 402,500. In this transaction EVP & Chief Operating Officer of this company sold 10,000 shares at a rate of $40.25, taking the stock ownership to the 3,029 shares. Before that another transaction happened on Dec 15, when Company’s EVP & Chief Operating Officer sold 15,000 for $40.32, making the entire transaction worth $604,800. This insider now owns 3,029 shares in total.
Tandem Diabetes Care Inc. (TNDM) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$0.24 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.02) by -$0.26. This company achieved a net margin of +2.21 while generating a return on equity of 3.89. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 142.90% per share during the next fiscal year.
Tandem Diabetes Care Inc. (NASDAQ: TNDM) Trading Performance Indicators
Check out the current performance indicators for Tandem Diabetes Care Inc. (TNDM). In the past quarter, the stock posted a quick ratio of 4.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.26. Likewise, its price to free cash flow for the trailing twelve months is 85.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc. (TNDM)
Analysing the last 5-days average volume posted by the [Tandem Diabetes Care Inc., TNDM], we can find that recorded value of 0.7 million was lower than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 45.79%. Additionally, its Average True Range was 2.33.
During the past 100 days, Tandem Diabetes Care Inc.’s (TNDM) raw stochastic average was set at 30.59%, which indicates a significant decrease from 40.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.36% in the past 14 days, which was lower than the 79.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.83, while its 200-day Moving Average is $58.09. Now, the first resistance to watch is $41.93. This is followed by the second major resistance level at $42.27. The third major resistance level sits at $42.61. If the price goes on to break the first support level at $41.25, it is likely to go to the next support level at $40.91. Should the price break the second support level, the third support level stands at $40.57.
Tandem Diabetes Care Inc. (NASDAQ: TNDM) Key Stats
There are currently 64,299K shares outstanding in the company with a market cap of 2.58 billion. Presently, the company’s annual sales total 702,800 K according to its annual income of 15,570 K. Last quarter, the company’s sales amounted to 204,550 K and its income totaled -48,970 K.